ExodusPoint Capital Management’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-5,737
Closed -$458K 3053
2021
Q1
$458K Sell
5,737
-7,910
-58% -$618K 0.01% 1429
2020
Q4
$1.08M Buy
13,647
+8,314
+156% +$488K 0.01% 817
2020
Q3
$234K Sell
5,333
-5,044
-49% -$249K ﹤0.01% 1405
2020
Q2
$459K Buy
+10,377
New +$387K 0.01% 1125
2020
Q1
Sell
-4,076
Closed -$289K 1851
2019
Q4
$289K Sell
4,076
-6,495
-61% -$471K 0.01% 1160
2019
Q3
$791K Buy
+10,571
New +$896K 0.03% 472

ExodusPoint Capital Management's CMD Position: Q2 2021 in Review

ExodusPoint Capital Management sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 5,737 shares — an estimated $458K sold.

ExodusPoint Capital Management first reported a position in CMD in Q3 2019 and held it in 6 quarters. The position peaked at $1.08M in Q4 2020. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

  • ExodusPoint Capital Management reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
  • ExodusPoint Capital Management sold 5,737 Cantel Medical Corporation shares in Q2 2021, an estimated $458K.
  • ExodusPoint Capital Management first reported a position in Cantel Medical Corporation in Q3 2019 and held it in 6 quarters.
  • ExodusPoint Capital Management's Cantel Medical Corporation position peaked at $1.08M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on ExodusPoint Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.